title: [A case of small cell lung carcinoma associated with pneumoconiosis who responded well to the over twenty chemotherapy treatments, resulting in prolonged survival].
abstract: In a 62-year-old man with pneumoconiosis (management 4), small cell lung carcinoma (intermediate cell type) was detected at the routine health examination for pneumoconiosis. The stage of the disease was III B (T2N3M0). Chemotherapy was undertaken over twenty times, resulting in a prolonged survival time (42.5 months). A case of this kind with small cell lung cancer responding well to repeated chemotherapy (decreased tumor size and tumor marker) until the terminal stage seems relatively rare and valuable.
authors.affiliation: First Dept. of Internal Medicine, Toyama Medical & Pharmaceutical University.
authors.forename: K
authors.initials: K
authors.lastname: Sassa
authors.forename: Y
authors.initials: Y
authors.lastname: Mizushima
authors.forename: Y
authors.initials: Y
authors.lastname: Yoshida
authors.forename: K
authors.initials: K
authors.lastname: Shinoda
authors.forename: M
authors.initials: M
authors.lastname: Kobayashi
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000150:complications / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011009:Pneumoconiosis / Q000150:complications*; D017741:Survivors; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin